MACRAMÉ Experts from University of Birmingham and 7Past9 together with many other experts published an article on challenges and future directions in assessing the quality and completeness of advanced materials safety data for re-usability.
On Monday, 19. January 2026, the European Health and Digital Executive Agency (HaDEA) will be holding the second edition of the HaDEA Showcase Event, we will highlight EU-funded projects and synergies from across HaDEA’s portfolio, in the context of key EU policy initiatives; the Competitiveness Compass and the EU Preparedness Union Strategy.
In 2025, MACRAMÉ Partners presented key results in posters and talks and attended panel discussions at various events.
MACRAMÉ colleagues from EMPA contributed to the publication ‘Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling’. For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals.
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted at the Organisation for Economic Cooperation and Development (OECD) in Paris and co-organised by four Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. Now, the full report of the event is available.
MACRAMÉ Partners presented key outcomes and used the great opportunity to discuss with many experts at the SSbD Conference 2025, 10th – 12th November, 2025 in Zurich (Switzerland)
The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA jointly organised an exclusive two-day virtual workshop advancing the harmonization and standardization of testing methodologies for nanomaterials and advanced materials.
Iseult Lynch from the MACRAMÉ Partner University of Birmingham co-authored a publication on the impact of mask use on micro(nano)plastic release.
Swaroop Chakraborty and Iseult Lynch from MACRAMÉ Partner University of Birmingham published an article on the influence of biocorona around engineered nanomaterials (ENM) on their environmental fate.
MyBiotech GmbH is a dynamic CDMO headquartered in Germany offering end-to-end development, manufacturing services, and cutting‑edge products for the biotechnology and pharmaceutical sectors. …
Continuing the NanoHarmony NANOMET journey: Harmonisation & Standardisation of Test Methodsfor Nanomaterials and Advanced Materials– Where did our research projects get us, and where do we go from here? *** ONLINE *** 3rd & 4th November 2025 The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA invite you to an exclusive
MACRAMÉ Experts used the opportunity to provide feedback in the commenting phase of the revision of the Safe and Sustainable by Design Chemicals and Materials Framework.
Sign up below to receive the MACRAMÉ Newsletter.
Continuing the NanoHarmony NANOMET journey:
Two Days focused on the Standardisation Roadmaps for in vitro Models and Graphene
*** ONLINE ***
22. – 23. November 2023, 10:00 – 15:00 CET
Challenges in addressing Sustainability in the Life Cycle Assessment of Products including Advanced Materials
*** BAuA, Berlin ***
27. – 28. November 2023
The MACRAMÉ to inform and train practitioners of advanced materials’ (AdMas’) safety and sustainability on and in topics pertaining to the harmonisation, standardisation and validation of characterisation- and test-methods of AdMAs.
Please follow this links below to find out more about each one of the webinars offered.
Date & Time: 09. April 2024, 14:00 – 16:00 CEST
Metrology, method validation, standardisation …
These concepts may sound complicated, but they are essential in analytical sciences. They strongly support the development of innovative products such as advanced materials or nanomedicine.
This webinar aims to help increase the impact of the protocols you are developing beyond the academic community and to get you updated on the new standards and reference materials on the horizon. … more …
Date & Time: 11. April 2024, 14:00 – 16:00 CEST
Regulatory safety testing of chemicals and materials is still mainly focused on animal testing. A huge number of New Approach Methodologies (NAMs) to replace or reduce animal testing have been scientifically developed within the last years. Their regulatory use, however, is still limited. A possible way to include NAMs into regulatory testing may be found in Adverse Outcome Pathways (AOPs). We will present what AOPs are, how they can be developed and established at OECD. The AOP for pulmonary fibrosis and the AOP on acute lung toxicity will serve as examples for the development of nanomaterial-relevant AOPs. We will discuss the implementation of AOPs into regulatory testing and hurdles. … more …
Date & Time: 04. March 2025, 14:00 – 16:00 CET
Advanced materials bring new challenges for regulatory risk assessment. The special properties of advanced materials may affect the applicability and predictivity of standard test methods for human health and environmental risk assessment. As a result, test methods may need to be adapted or newly developed.
The webinar will inform you about different standardisation organisations (e.g. ISO, CEN, OECD) and the process towards an accepted standard. This includes the important steps of method validation and regulatory acceptance. An overview of the state-of-the-art of human health and environmental in vitro testing of the advanced materials will be given. Challenges and ways to overcome these will be discussed. Topics include stable dispersions, characterisation of materials in test media, alternative testing approaches and dosimetry.
Join us for an interactive webinar with participants from academia, industry and regulation. … more …
Date & Time: 25. Sept. 2025, 14:00 – 16:00 CEST
Advanced materials go beyond conventional nanomaterials in complexity and functionality, which may bring additional challenges in their risk assessment. The MACRAMÉ Informed Recommendations address critical gaps in the standardisation of testing and risk assessment for advanced materials and highlight the regulatory needs for further developments of test and assessment strategies. The recommendations reflect the scientific and technical knowledge gained during the development of testing methodologies for advanced materials, as well as expert input from regulatory and policy consultations.
Within this interactive webinar we aim to gain your feedback on the recommendations. This will help us refine and further develop the recommendations. Your input will thus support the efforts to align testing strategies with regulatory needs and contribute to more targeted and applicable test method development. . … more …
Continuing the NanoHarmony NANOMET journey:
Two Days focused on the Standardisation Roadmaps for in vitro Models and Graphene
*** ONLINE ***
18th & 19th November 2024
19th & 20th June 2025
OECD Conference Centre, Paris
Continuing the NanoHarmony NANOMET journey:
– Where did our research projects get us, and where do we go from here?
*** ONLINE ***
3rd & 4th November 2025
The MACRAMÉ experts are delighted to share their achievements with experts working at the intersection of materials innovation and regulatory compliance. The project has advanced characterisation methodologies to assess and predict the health and environmental risks of advanced materials.
*** ONLINE ***
6th May 2026
